Total Payments
$5,600
2024 Payments
$574.97
Companies
10
Transactions
19
Medicare Patients
454
Medicare Billing
$109,071
Payment Breakdown by Category
Other$3,782 (67.5%)
Gifts$885.00 (15.8%)
Food & Beverage$833.25 (14.9%)
Education$99.99 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,782 | 2 | 67.5% |
| Gift | $885.00 | 3 | 15.8% |
| Food and Beverage | $833.25 | 13 | 14.9% |
| Education | $99.99 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $4,024 | 6 | $0 (2024) |
| Sekisui Diagnostics, LLC | $885.00 | 3 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $148.62 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $121.51 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $99.99 | 1 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $96.00 | 1 | $0 (2018) |
| Daiichi Sankyo Inc. | $88.57 | 1 | $0 (2024) |
| UCB, Inc. | $82.38 | 3 | $0 (2023) |
| Incyte Corporation | $29.57 | 1 | $0 (2024) |
| Seagen Inc. | $25.10 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $574.97 | 6 | Sekisui Diagnostics, LLC ($250.00) |
| 2023 | $4,396 | 8 | SANOFI-AVENTIS U.S. LLC ($3,938) |
| 2022 | $375.00 | 1 | Sekisui Diagnostics, LLC ($375.00) |
| 2020 | $37.79 | 1 | UCB, Inc. ($37.79) |
| 2019 | $120.59 | 2 | Astellas Pharma US Inc ($99.99) |
| 2018 | $96.00 | 1 | Alexion Pharmaceuticals, Inc. ($96.00) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $29.57 | General |
| Category: Hematology/Oncology | ||||||
| 12/08/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $56.21 | General |
| Category: Oncology | ||||||
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $121.51 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $88.57 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $250.00 | General |
| 12/12/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Oncology | ||||||
| 10/18/2023 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,764.00 | General |
| 10/18/2023 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $128.25 | General |
| 10/18/2023 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $18.00 | General |
| 09/08/2023 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $148.62 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/28/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Neurology | ||||||
| 06/21/2023 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Oncology | ||||||
| 01/01/2023 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $260.00 | General |
| 01/01/2022 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $375.00 | General |
| 10/24/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $37.79 | General |
| Category: Neurology | ||||||
| 07/09/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Neurology | ||||||
| 04/18/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 08/08/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $96.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 123 | 410 | $112,913 | $29,877 |
| 2022 | 4 | 79 | 248 | $78,170 | $16,058 |
| 2021 | 6 | 131 | 473 | $143,669 | $33,229 |
| 2020 | 4 | 121 | 446 | $126,856 | $29,907 |
Total Patients
454
Total Services
1,577
Medicare Billing
$109,071
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 256 | $58,542 | $16,270 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 28 | $14,955 | $3,232 | 21.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 33 | $10,135 | $3,132 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 38 | $10,206 | $2,897 | 28.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $9,019 | $2,015 | 22.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $5,202 | $1,166 | 22.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 29 | $4,854 | $1,165 | 24.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 128 | $37,896 | $7,090 | 18.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 80 | $29,222 | $6,308 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 20 | $7,497 | $2,062 | 27.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 20 | $3,555 | $597.70 | 16.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 33 | 149 | $51,496 | $12,012 | 23.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 34 | 210 | $59,542 | $11,879 | 20.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 25 | 61 | $22,548 | $6,491 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 21 | $5,268 | $1,537 | 29.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 15 | 17 | $4,137 | $956.76 | 23.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 11 | 15 | $678.00 | $353.78 | 52.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 41 | 162 | $53,486 | $13,323 | 24.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 42 | 187 | $50,019 | $10,695 | 21.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 26 | 84 | $20,292 | $5,143 | 25.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 12 | 13 | $3,059 | $746.91 | 24.4% |
About Dr. George Chen, MD
Dr. George Chen, MD is a Hematology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1366757775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Chen, MD has received a total of $5,600 in payments from pharmaceutical and medical device companies, with $574.97 received in 2024. These payments were reported across 19 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,782).
As a Medicare-enrolled provider, Chen has provided services to 454 Medicare beneficiaries, totaling 1,577 services with total Medicare billing of $109,071. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology, Hematology
- Location Houston, TX
- Active Since 08/10/2010
- Last Updated 03/01/2023
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1366757775
Products in Payments
- VYXEOS (Drug) $148.62
- DARZALEX (Biological) $121.51
- REZUROCK (Drug) $113.25
- SOLIRIS (Drug) $96.00
- Vanflyta (Drug) $88.57
- Briviact (Drug) $82.38
- JAKAFI (Drug) $29.57
- ADCETRIS (Biological) $25.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Houston
Loretta Nastoupil, M.d, M.D
Hematology — Payments: $569,768
Hematology $569,768
Kelty Baker, Md, MD
Hematology — Payments: $301,763
Hematology $301,763
Dr. Siddhartha Ganguly, M.d, M.D
Hematology — Payments: $238,662
Hematology $238,662
Lawrence Rice, M.d, M.D
Hematology — Payments: $88,796
Hematology $88,796
Dr. Modupe Idowu, M.d, M.D
Hematology — Payments: $88,441
Hematology $88,441
Carlos Bueso-Ramos, M.d., Phd, M.D., PHD
Hematology — Payments: $41,524
Hematology $41,524